Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• Long intergenic non-coding RNAs (lncRNAs) are an under-studied class of transcripts implicated in human cancers.
• Their tissue- and cancer-specific expression suggests potential as diagnostic biomarkers.
• Many lncRNAs remain elusive without specific tumor type examination.

Purpose of the Study:

• To characterize the lncRNA landscape in lung cancer.
• To identify novel lncRNAs and differentially expressed lung cancer-associated lncRNAs (LCALs).
• To explore the association of LCALs with oncogene mutations and their functional roles.

Main Methods:

• Analysis of publicly available transcriptome sequencing data from 567 lung tumors (adenocarcinoma and squamous cell carcinoma).
• Identification of unannotated intergenic transcripts as novel lncRNAs.
• Pan-cancer analysis of 324 tumor/normal pairs and integration with exome sequencing data.
• Functional validation via knockdown and overexpression experiments.

Main Results:

• Over 3,000 novel lncRNAs were identified.
• 111 differentially expressed lncRNAs (LCALs) were discovered in lung cancer.
• LCALs showed lung cancer-specific or broad deregulation across cancers.
• LCAL expression correlated with oncogene mutational status.
• LCAL1 was shown to play a role in cellular proliferation.

Conclusions:

• Systematic characterization of lung cancer lncRNAs provides a foundation for future research.
• Identified LCALs offer potential for novel biomarker development.
• This work enhances the understanding of lung tumor biology.